{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T14:30:32Z","timestamp":1794580232807,"version":"4.9.1"},"reference-count":157,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T00:00:00Z","timestamp":1667174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>ANCA-associated vasculitides (AAV) are a group of rare, primary, systemic necrotizing small-vessel vasculitides. Granulomatosis with polyangiitis and microscopic polyangiitis account for \u223c80\u201390% of all AAV. Exposure to silica dust, farming and chronic nasal Staphylococcus aureus carriage are associated with increased risk of developing AAV. When a diagnosis of AAV is suspected, as in patients with multisystem organ dysfunction or those with features such as chronic recurrent rhinosinusitis, cavitated lung nodules, palpable purpura or acute kidney injury, then appropriate further investigations are needed, including ANCA testing. In this scenario, a structured clinical assessment should be conducted, evaluating all the organs possibly involved, and tissue biopsy may be necessary for confirmation of the diagnosis. Therapeutic algorithms vary based on the severity of AAV, the clinical diagnosis\/ANCA specificity, and the patient\u2019s age, weight, comorbidities and prognosis. Recent data favour rituximab as a preferable option for both induction and maintenance of remission. In addition, regimens with less glucocorticoids are equally effective and safer in inducing remission compared with conventional regimens, and avacopan is an effective glucocorticoid-sparing option. In contrast, there is not compelling evidence to support the routine use of plasma exchange in addition to standard remission-induction therapy in AAV. ANCA and other biomarkers can be helpful in association with clinical assessment to guide diagnosis and treatment decisions. Patients should be frequently evaluated during follow-up for possible disease relapses or treatment-related morbidity, and for monitoring damage accrual, especially metabolic and cardiovascular damage.<\/jats:p>","DOI":"10.1093\/rheumatology\/keac623","type":"journal-article","created":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T10:33:14Z","timestamp":1667039594000},"page":"1787-1803","source":"Crossref","is-referenced-by-count":77,"title":["Diagnosing and treating ANCA-associated vasculitis: an updated review for clinical practice"],"prefix":"10.1093","volume":"62","author":[{"given":"Baptiste","family":"Chevet","sequence":"first","affiliation":[{"name":"LBAI, UMR1227, Univ Brest, Inserm, Labex IGO, CHU de Brest , Brest, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divi","family":"Cornec","sequence":"additional","affiliation":[{"name":"LBAI, UMR1227, Univ Brest, Inserm, Labex IGO, CHU de Brest , Brest, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7439-6501","authenticated-orcid":false,"given":"Marta","family":"Casal Moura","sequence":"additional","affiliation":[{"name":"Department Division of Pulmonary and Critical Care Medicine, Department of Medicine, and Thoracic Research Disease Unit, Mayo Clinic College of Medicine and Science , Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Cornec-Le Gall","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Univ Brest, Inserm, UMR 1078, GGB , Brest, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9952-209X","authenticated-orcid":false,"given":"Fernando C","family":"Fervenza","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Mayo Clinic , Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7708-2487","authenticated-orcid":false,"given":"Kenneth J","family":"Warrington","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Mayo Clinic , Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Specks","sequence":"additional","affiliation":[{"name":"Department Division of Pulmonary and Critical Care Medicine, Department of Medicine, and Thoracic Research Disease Unit, Mayo Clinic College of Medicine and Science , Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7831-921X","authenticated-orcid":false,"given":"Alvise","family":"Berti","sequence":"additional","affiliation":[{"name":"Rheumatology, Santa Chiara Regional Hospital, APSS Trento, and Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,10,31]]},"reference":[{"key":"2023050208180076900_keac623-B1","first-page":"S11","article-title":"Epidemiological study of primary systemic vasculitides among adults in southern Spain and review of the main epidemiological studies","volume":"33","author":"Romero-G\u00f3mez","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"2023050208180076900_keac623-B2","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1002\/art.40313","article-title":"The epidemiology of antineutrophil cytoplasmic autoantibody-associated vasculitis in olmsted county, Minnesota: a twenty-year US population-based study","volume":"69","author":"Berti","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2023050208180076900_keac623-B3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41572-020-0204-y","article-title":"ANCA-associated vasculitis","volume":"6","author":"Kitching","year":"2020","journal-title":"Nat Rev Dis Primer"},{"key":"2023050208180076900_keac623-B4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.berh.2018.09.001","article-title":"Update on the epidemiology, risk factors, and outcomes of systemic vasculitides","volume":"32","author":"Berti","year":"2018","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2023050208180076900_keac623-B5","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1136\/ard.60.2.170","article-title":"Geoepidemiology of systemic vasculitis: comparison of the incidence in two regions of Europe","volume":"60","author":"Watts","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"2023050208180076900_keac623-B6","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.4081\/rr.2010.e8","article-title":"Wegener\u2019s granulomatosis and environmental factors in Western Montana","volume":"2","author":"Zeft","year":"2010","journal-title":"Rheumatol Rep"},{"key":"2023050208180076900_keac623-B7","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1093\/rheumatology\/ker205","article-title":"Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the U.K","volume":"50","author":"Fujimoto","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"2023050208180076900_keac623-B8","first-page":"409","article-title":"The epidemiology of primary systemic vasculitides involving small vessels in Crete (southern Greece): a comparison of older versus younger adult patients","volume":"27","author":"Panagiotakis","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"2023050208180076900_keac623-B9","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1186\/s13023-020-01621-3","article-title":"French recommendations for the management of systemic necrotizing vasculitides (polyarteritis nodosa and ANCA-associated vasculitides)","volume":"15","author":"Terrier","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"2023050208180076900_keac623-B10","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/art.20077","article-title":"Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener\u2019s granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate","volume":"51","author":"Mahr","year":"2004","journal-title":"Arthritis Rheum"},{"key":"2023050208180076900_keac623-B11","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1136\/bmj.e26","article-title":"Diagnosis and management of ANCA associated vasculitis","volume":"344","author":"Berden","year":"2012","journal-title":"BMJ"},{"key":"2023050208180076900_keac623-B12","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0140-6736(02)11279-7","article-title":"Incidence of Henoch-Sch\u00f6nlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins","volume":"360","author":"Gardner-Medwin","year":"2002","journal-title":"Lancet"},{"key":"2023050208180076900_keac623-B13","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1056\/NEJMoa1108735","article-title":"Genetically distinct subsets within ANCA-associated vasculitis","volume":"367","author":"Lyons","year":"2012","journal-title":"N Engl J Med"},{"key":"2023050208180076900_keac623-B14","doi-asserted-by":"crossref","first-page":"102660","DOI":"10.1016\/j.autrev.2020.102660","article-title":"Environmental risk factors associated with ANCA associated vasculitis: a systematic mapping review","volume":"19","author":"Scott","year":"2020","journal-title":"Autoimmun Rev"},{"key":"2023050208180076900_keac623-B15","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0272-6386(00)70260-5","article-title":"Significantly high regional morbidity of MPO-ANCA-related angitis and\/or nephritis with respiratory tract involvement after the 1995 great earthquake in Kobe (Japan)","volume":"35","author":"Yashiro","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"2023050208180076900_keac623-B16","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.autrev.2013.06.016","article-title":"The association between silica exposure and development of ANCA-associated vasculitis: systematic review and meta-analysis","volume":"12","author":"G\u00f3mez-Puerta","year":"2013","journal-title":"Autoimmun Rev"},{"key":"2023050208180076900_keac623-B17","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1002\/art.41767","article-title":"Prevalence of antineutrophil cytoplasmic antibody-associated vasculitis and spatial association with quarries in a region of northeastern france: a capture-recapture and geospatial analysis","volume":"73","author":"Giorgiutti","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"2023050208180076900_keac623-B18","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1001\/jamainternmed.2020.0675","article-title":"Association of cigarette smoking with antineutrophil cytoplasmic antibody-associated vasculitis","volume":"180","author":"McDermott","year":"2020","journal-title":"JAMA Intern Med"},{"key":"2023050208180076900_keac623-B19","first-page":"361","article-title":"Smoking is a risk factor for relapse of antimyeloperoxidase antibodies-associated vasculitis","volume":"24","author":"Yamaguchi","year":"2018","journal-title":"J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis"},{"key":"2023050208180076900_keac623-B20","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1136\/ard.2004.033191","article-title":"Smoking habits in patients diagnosed with ANCA associated small vessel vasculitis","volume":"64","author":"Haubitz","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"2023050208180076900_keac623-B21","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1093\/rheumatology\/kex512","article-title":"Novel insights into the aetiology of granulomatosis with polyangiitis\u2014a case\u2013control study using the Clinical Practice Research Datalink","volume":"57","author":"Pearce","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"2023050208180076900_keac623-B22","doi-asserted-by":"crossref","first-page":"e0137196","DOI":"10.1371\/journal.pone.0137196","article-title":"Farm exposure as a differential risk factor in ANCA-associated vasculitis","volume":"10","author":"Willeke","year":"2015","journal-title":"PLoS ONE"},{"key":"2023050208180076900_keac623-B23","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1136\/annrheumdis-2018-213645","article-title":"Characterisation of the nasal microbiota in granulomatosis with polyangiitis","volume":"77","author":"Rhee","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2023050208180076900_keac623-B24","first-page":"51","article-title":"Nasal carriage of Staphylococcus aureus and endonasal activity in Wegener s granulomatosis as compared to rheumatoid arthritis and chronic rhinosinusitis with nasal polyps","volume":"28","author":"Laudien","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"2023050208180076900_keac623-B25","doi-asserted-by":"crossref","first-page":"12","DOI":"10.7326\/0003-4819-120-1-199401010-00003","article-title":"Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis","volume":"120","author":"Stegeman","year":"1994","journal-title":"Ann Intern Med"},{"key":"2023050208180076900_keac623-B26","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/2047-783X-14-S4-265","article-title":"Co-trimoxazole and prevention of relapses of PR3-ANCA positive vasculitis with pulmonary involvement","volume":"14","author":"Zycinska","year":"2009","journal-title":"Eur J Med Res"},{"key":"2023050208180076900_keac623-B27","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/nrneph.2012.108","article-title":"Propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis","volume":"8","author":"Chen","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"2023050208180076900_keac623-B28","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/BOR.0000000000000014","article-title":"Trojan horses: drug culprits associated with antineutrophil cytoplasmic autoantibody (ANCA) vasculitis","volume":"26","author":"Pendergraft","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"2023050208180076900_keac623-B29","doi-asserted-by":"crossref","first-page":"e0894","DOI":"10.1002\/rcr2.894","article-title":"Association of COVID-19 antigenicity with the development of antineutrophilic cytoplasmic antibody vasculitis","volume":"10","author":"Felzer","year":"2022","journal-title":"Respirol Case Rep"},{"key":"2023050208180076900_keac623-B30","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3390\/vaccines10050653","article-title":"Dual-positive MPO- and PR3-ANCA-associated vasculitis following SARS-CoV-2 mRNA booster vaccination: a case report and systematic review","volume":"10","author":"Baier","year":"2022","journal-title":"Vaccines"},{"key":"2023050208180076900_keac623-B31","doi-asserted-by":"crossref","first-page":"102618","DOI":"10.1016\/j.autrev.2020.102618","article-title":"2020 international consensus on ANCA testing beyond systemic vasculitis","volume":"19","author":"Moiseev","year":"2020","journal-title":"Autoimmun Rev"},{"key":"2023050208180076900_keac623-B32","doi-asserted-by":"crossref","first-page":"102716","DOI":"10.1016\/j.autrev.2020.102716","article-title":"The value of anti-neutrophil cytoplasmic antibodies (ANCA) testing for the diagnosis of ANCA-associated vasculitis, a systematic review and meta-analysis","volume":"20","author":"Guchelaar","year":"2021","journal-title":"Autoimmun Rev"},{"key":"2023050208180076900_keac623-B33","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1136\/annrheumdis-2016-209507","article-title":"Detection of antineutrophil cytoplasmic antibodies (ANCAs): a multicentre European Vasculitis Study Group (EUVAS) evaluation of the value of indirect immunofluorescence (IIF) versus antigen-specific immunoassays","volume":"76","author":"Damoiseaux","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2023050208180076900_keac623-B34","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.rdc.2010.05.009","article-title":"Diagnostic approach to ANCA-associated vasculitides","volume":"36","author":"Gaffo","year":"2010","journal-title":"Rheum Dis Clin N Am"},{"key":"2023050208180076900_keac623-B35","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s40620-017-0412-z","article-title":"ANCA-associated vasculitis with renal involvement","volume":"31","author":"Binda","year":"2018","journal-title":"J Nephrol"},{"key":"2023050208180076900_keac623-B36","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.3899\/jrheum.121473","article-title":"New features of disease after diagnosis in 6 forms of systemic vasculitis","volume":"40","author":"Grayson","year":"2013","journal-title":"J Rheumatol"},{"key":"2023050208180076900_keac623-B37","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.berh.2018.10.001","article-title":"Clinical features and structured clinical evaluation of vasculitis","volume":"32","author":"Ponte","year":"2018","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2023050208180076900_keac623-B38","doi-asserted-by":"crossref","first-page":"e6083","DOI":"10.1097\/MD.0000000000006083","article-title":"Clinical characteristics and outcome of Spanish patients with ANCA-associated vasculitides","volume":"96","author":"Solans-Laqu\u00e9","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"2023050208180076900_keac623-B39","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1046\/j.1523-1755.2000.057003846.x","article-title":"Antineutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features","volume":"57","author":"Savige","year":"2000","journal-title":"Kidney Int"},{"key":"2023050208180076900_keac623-B40","first-page":"286030","article-title":"Top differential diagnosis should be microscopic polyangiitis in ANCA-positive patient with diffuse pulmonary hemorrhage and hemosiderosis","volume":"2014","author":"Ward","year":"2014","journal-title":"Case Rep Pathol"},{"key":"2023050208180076900_keac623-B41","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s00296-019-04282-z","article-title":"Should nasal biopsy inevitably be performed for classifying granulomatosis with polyangiitis in patients with rhinosinusitis? A retrospective chart review study","volume":"39","author":"Yoo","year":"2019","journal-title":"Rheumatol Int"},{"key":"2023050208180076900_keac623-B42","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s40120-021-00315-7","article-title":"ANCA-associated vasculitic neuropathies: a review","volume":"11","author":"Koike","year":"2022","journal-title":"Neurol Ther"},{"key":"2023050208180076900_keac623-B43","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/rheumatology\/keaa233","article-title":"Muscle biopsy in anti-neutrophil cytoplasmic antibody-associated vasculitis: diagnostic yield depends on anti-neutrophil cytoplasmic antibody type, sex and neutrophil count","volume":"60","author":"Lacou","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2023050208180076900_keac623-B44","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1600-0560.2006.00699.x","article-title":"Cutaneous manifestations of Wegener\u2019s granulomatosis: a clinicopathologic study of 17 patients and correlation to antineutrophil cytoplasmic antibody status","volume":"34","author":"Comfere","year":"2007","journal-title":"J Cutan Pathol"},{"key":"2023050208180076900_keac623-B45","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/ndt\/16.5.953","article-title":"Renal histopathology and clinical course in 94 patients with Wegener\u2019s granulomatosis","volume":"16","author":"Aasar\u00f8d","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"2023050208180076900_keac623-B46","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/0003-4819-116-6-488","article-title":"Wegener granulomatosis: an analysis of 158 patients","volume":"116","author":"Hoffman","year":"1992","journal-title":"Ann Intern Med"},{"key":"2023050208180076900_keac623-B47","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/00000478-199006000-00006","article-title":"Interpretation of head and neck biopsies in Wegener\u2019s granulomatosis. A pathologic study of 126 biopsies in 70 patients","volume":"14","author":"Devaney","year":"1990","journal-title":"Am J Surg Pathol"},{"key":"2023050208180076900_keac623-B48","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1183\/09031936.97.10122738","article-title":"Efficacy of transbronchial biopsy in pulmonary vaculitides","volume":"10","author":"Schnabel","year":"1997","journal-title":"Eur Respir J"},{"key":"2023050208180076900_keac623-B49","first-page":"188","article-title":"Wegener\u2019s granulomatosis\u2013a review of diagnosis and treatment in 53 subjects","volume":"36","author":"Jennings","year":"1998","journal-title":"Rhinology"},{"key":"2023050208180076900_keac623-B50","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2500\/ajra.2012.26.3825","article-title":"Diagnostic value of biopsies in identifying cytoplasmic antineutrophil cytoplasmic antibody-negative localized Wegener\u2019s granulomatosis presenting primarily with sinonasal disease","volume":"26","author":"Borner","year":"2012","journal-title":"Am J Rhinol Allergy"},{"key":"2023050208180076900_keac623-B51","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0242-6498(05)86171-1","article-title":"Comment am\u00e9liorer la rentabilit\u00e9 diagnostique des biopsies de la sph\u00e8re oto-rhino-laryng\u00e9e dans la maladie de Wegener: analyse anatomo-clinique de 49 biopsies chez 21 patients","volume":"25","author":"Raynaud","year":"2005","journal-title":"Ann Pathol"},{"key":"2023050208180076900_keac623-B52","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0161-6420(92)32028-7","article-title":"Diagnostic value and limitations of orbital biopsy in Wegener\u2019s granutomatosis","volume":"99","author":"Kalina","year":"1992","journal-title":"Ophthalmology"},{"key":"2023050208180076900_keac623-B53","doi-asserted-by":"crossref","first-page":"e615","DOI":"10.1212\/NXI.0000000000000615","article-title":"Peripheral neuropathy in antineutrophil cytoplasmic antibody-associated vasculitides: insights from the DCVAS study","volume":"6","author":"Bischof","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2023050208180076900_keac623-B54","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1007\/s10157-012-0736-x","article-title":"Skin involvement in ANCA-associated vasculitis","volume":"17","author":"Chen","year":"2013","journal-title":"Clin Exp Nephrol"},{"key":"2023050208180076900_keac623-B55","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1136\/annrheumdis-2016-209133","article-title":"EULAR\/ERA-EDTA recommendations for the management of ANCA-associated vasculitis","volume":"75","author":"Yates","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2023050208180076900_keac623-B56","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/annrheumdis-2021-221796","article-title":"American College of Rheumatology\/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis","volume":"81","author":"Suppiah","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"2023050208180076900_keac623-B57","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/annrheumdis-2021-221795","article-title":"American College of Rheumatology\/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis","volume":"81","author":"Robson","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"2023050208180076900_keac623-B58","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1093\/ndt\/gfab250","article-title":"Kidney biopsy chronicity grading in antineutrophil cytoplasmic antibody associated vasculitis","volume":"37","author":"Moura","year":"2022","journal-title":"Nephrol Dial Transplant"},{"key":"2023050208180076900_keac623-B59","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/art.1780330807","article-title":"The American College of Rheumatology 1990 criteria for the classification of Wegener\u2019s granulomatosis","volume":"33","author":"Leavitt","year":"1990","journal-title":"Arthritis Rheum"},{"key":"2023050208180076900_keac623-B60","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa041884","article-title":"Etanercept plus standard therapy for Wegener\u2019s granulomatosis","volume":"352","author":"Stone","year":"2005","journal-title":"N Engl J Med"},{"key":"2023050208180076900_keac623-B61","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/acr.20649","article-title":"Assessment of health related quality of life as an outcome measure in granulomatosis with polyangiitis (Wegener\u2019s)","volume":"64","author":"Tomasson","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2023050208180076900_keac623-B62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill consensus conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2023050208180076900_keac623-B63","author":"Barnard","year":"2022"},{"key":"2023050208180076900_keac623-B64","first-page":"104039","article-title":"Lung involvement in ANCA-associated vasculitis","volume":"49","author":"Sacoto","year":"2020","journal-title":"Presse Med 1983"},{"key":"2023050208180076900_keac623-B65","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.rdc.2018.06.001","article-title":"Renal involvement in antineutrophil cytoplasmic antibody-associated vasculitis","volume":"44","author":"Zonozi","year":"2018","journal-title":"Rheum Dis Clin North Am"},{"key":"2023050208180076900_keac623-B66","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/MD.0b013e318239add6","article-title":"Urogenital manifestations in wegener granulomatosis: a study of 11 cases and review of the literature","volume":"91","author":"Dufour","year":"2012","journal-title":"Medicine (Baltimore)"},{"key":"2023050208180076900_keac623-B67","doi-asserted-by":"crossref","first-page":"E38","DOI":"10.5489\/cuaj.3555","article-title":"Acute urinary retention secondary to urethral involvement of granulomatosis with polyangiitis","volume":"11","author":"Anderson","year":"2017","journal-title":"Can Urol Assoc J"},{"key":"2023050208180076900_keac623-B68","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s12016-017-8616-5","article-title":"Cutaneous manifestations of ANCA-associated small vessels vasculitis","volume":"53","author":"Marzano","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"2023050208180076900_keac623-B69","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.abd.2021.02.008","article-title":"Skin manifestations associated with systemic diseases - Part I","volume":"96","author":"Sampaio","year":"2021","journal-title":"An Bras Dermatol"},{"key":"2023050208180076900_keac623-B70","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1111\/bjd.17701","article-title":"Image gallery: strawberry gingivitis as first sign of granulomatosis with polyangiitis","volume":"180","author":"Atarbashi-Moghadam","year":"2019","journal-title":"Br J Dermatol"},{"key":"2023050208180076900_keac623-B71","first-page":"355","article-title":"Genital ulcers: differential diagnosis and management","volume":"101","author":"Roett","year":"2020","journal-title":"Am Fam Physician"},{"key":"2023050208180076900_keac623-B72","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.anl.2020.07.004","article-title":"Clinical characteristics, the diagnostic criteria and management recommendation of otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV) proposed by Japan Otological Society","volume":"48","author":"Harabuchi","year":"2021","journal-title":"Auris Nasus Larynx"},{"key":"2023050208180076900_keac623-B73","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/BOR.0000000000000665","article-title":"Vasculitis and the ear: a literature review","volume":"32","author":"Rahne","year":"2020","journal-title":"Curr Opin Rheumatol"},{"key":"2023050208180076900_keac623-B74","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.21037\/jtd.2019.11.43","article-title":"Idiopathic subglottic stenosis: a review","volume":"12","author":"Aravena","year":"2020","journal-title":"J Thorac Dis"},{"key":"2023050208180076900_keac623-B75","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.semarthrit.2005.12.003","article-title":"Wegener\u2019s granulomatosis: ophthalmic manifestations and management","volume":"35","author":"Pakrou","year":"2006","journal-title":"Semin Arthritis Rheum"},{"key":"2023050208180076900_keac623-B76","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.3389\/fneur.2018.01166","article-title":"Central nervous system involvement in ANCA-associated vasculitis: what neurologists need to know","volume":"9","author":"Zheng","year":"2018","journal-title":"Front Neurol"},{"key":"2023050208180076900_keac623-B77","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-3-030-38490-6_8","volume-title":"Diseases of the brain, head and neck, spine 2020\u20132023: diagnostic imaging","author":"Smirniotopoulos","year":"2020"},{"key":"2023050208180076900_keac623-B78","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jns.2016.06.024","article-title":"Hypertrophic pachymeningitis","volume":"367","author":"Hahn","year":"2016","journal-title":"J Neurol Sci"},{"key":"2023050208180076900_keac623-B79","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000076995","article-title":"The heart in Wegener\u2019s granulomatosis","volume":"102","author":"Korantzopoulos","year":"2004","journal-title":"Cardiology"},{"key":"2023050208180076900_keac623-B80","doi-asserted-by":"crossref","first-page":"102940","DOI":"10.1016\/j.autrev.2021.102940","article-title":"Salivary gland involvement in ANCA-associated vasculitis","volume":"20","author":"Akiyama","year":"2021","journal-title":"Autoimmun Rev"},{"key":"2023050208180076900_keac623-B81","first-page":"253","article-title":"Diagnostic diff\u00e9rentiel des syndromes secs et parotidom\u00e9galies","volume":"85","author":"Tison","year":"2018","journal-title":"Rev Rhum Monogr"},{"key":"2023050208180076900_keac623-B82","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/pgmj.69.817.856","article-title":"Prognostic factors in Wegener\u2019s granulomatosis","volume":"69","author":"Briedigkeit","year":"1993","journal-title":"Postgrad Med J"},{"key":"2023050208180076900_keac623-B83","volume-title":"StatPearls","author":"Qasim","year":"2022"},{"key":"2023050208180076900_keac623-B84","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.kint.2017.03.014","article-title":"Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients","volume":"92","author":"McAdoo","year":"2017","journal-title":"Kidney Int"},{"key":"2023050208180076900_keac623-B85","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1053\/j.ajkd.2005.05.003","article-title":"Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis","volume":"46","author":"Rutgers","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"2023050208180076900_keac623-B86","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1016\/j.jccase.2010.04.002","article-title":"Cardiac manifestations of Wegener\u2019s granulomatosis: case report and review of the literature","volume":"2","author":"Ruisi","year":"2010","journal-title":"J Cardiol Cases"},{"key":"2023050208180076900_keac623-B87","first-page":"64","article-title":"Rituximab versus cyclophosphamide for central nervous system involvement of antineutrophil cytoplasmic antibody-associated vasculitis: a case series","volume":"27","author":"Krishna","year":"2021","journal-title":"J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis"},{"key":"2023050208180076900_keac623-B88","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/acr.24634","article-title":"2021 American College of Rheumatology\/Vasculitis Foundation guideline for the management of antineutrophil cytoplasmic antibody\u2013associated vasculitis","volume":"73","author":"Chung","year":"2021","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2023050208180076900_keac623-B89","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12882-019-1226-0","article-title":"Intravenous pulse methylprednisolone for induction of remission in severe ANCA associated vasculitis: a multi-center retrospective cohort study","volume":"20","author":"Chanouzas","year":"2019","journal-title":"BMC Nephrol"},{"key":"2023050208180076900_keac623-B90","doi-asserted-by":"crossref","first-page":"670","DOI":"10.7326\/0003-4819-150-10-200905190-00004","article-title":"Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody\u2013associated vasculitis: a randomized trial","volume":"150","author":"de Groot","year":"2009","journal-title":"Ann Intern Med"},{"key":"2023050208180076900_keac623-B91","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1056\/NEJMoa0802311","article-title":"Azathioprine or methotrexate maintenance for ANCA-associated vasculitis","volume":"359","author":"Pagnoux","year":"2008","journal-title":"N Engl J Med"},{"key":"2023050208180076900_keac623-B92","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/art.39011","article-title":"Treatment of systemic necrotizing vasculitides in patients aged sixty-five years or older: results of a multicenter, open-label, randomized controlled trial of corticosteroid and cyclophosphamide-based induction therapy","volume":"67","author":"Pagnoux","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2023050208180076900_keac623-B93","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/1529-0131(200104)44:4<912::AID-ANR148>3.0.CO;2-5","article-title":"A disease-specific activity index for Wegener\u2019s granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS)","volume":"44","author":"Stone","year":"2001","journal-title":"Arthritis Rheum"},{"key":"2023050208180076900_keac623-B94","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1056\/NEJMoa1803537","article-title":"Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis","volume":"382","author":"Walsh","year":"2020","journal-title":"N Engl J Med"},{"key":"2023050208180076900_keac623-B95","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa2023386","article-title":"Avacopan for the treatment of ANCA-associated vasculitis","volume":"384","author":"Jayne","year":"2021","journal-title":"N Engl J Med"},{"key":"2023050208180076900_keac623-B96","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1001\/jama.2021.6615","article-title":"Effect of reduced-dose vs high-dose glucocorticoids added to rituximab on remission induction in ANCA-associated vasculitis: a randomized clinical trial","volume":"325","author":"Furuta","year":"2021","journal-title":"JAMA"},{"key":"2023050208180076900_keac623-B97","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1136\/annrheumdis-2019-216863","article-title":"Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis","volume":"79","author":"Smith","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2023050208180076900_keac623-B98","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/acr.20176","article-title":"Effects of duration of glucocorticoid therapy on relapse rate in antineutrophil cytoplasmic antibody-associated vasculitis: a meta-analysis","volume":"62","author":"Walsh","year":"2010","journal-title":"Arthritis Care Res"},{"key":"2023050208180076900_keac623-B99","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1136\/annrheumdis-2015-208073","article-title":"Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type","volume":"75","author":"Unizony","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2023050208180076900_keac623-B100","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"Stone","year":"2010","journal-title":"N Engl J Med"},{"key":"2023050208180076900_keac623-B101","first-page":"100","article-title":"Malignancies in Wegener\u2019s granulomatosis: incidence and relation to cyclophosphamide therapy in a cohort of 293 patients","volume":"35","author":"Faurschou","year":"2008","journal-title":"J Rheumatol"},{"key":"2023050208180076900_keac623-B102","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa0909169","article-title":"Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis","volume":"363","author":"Jones","year":"2010","journal-title":"N Engl J Med"},{"key":"2023050208180076900_keac623-B103","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1213277","article-title":"Efficacy of remission-induction regimens for ANCA-associated vasculitis","volume":"369","author":"Specks","year":"2013","journal-title":"N Engl J Med"},{"key":"2023050208180076900_keac623-B104","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/acr2.11274","article-title":"Comparison of two rituximab induction regimens for antineutrophil cytoplasm antibody-associated vasculitis: systematic review and meta-analysis","volume":"3","author":"B\u00e9nard","year":"2021","journal-title":"ACR Open Rheumatol"},{"key":"2023050208180076900_keac623-B105","doi-asserted-by":"crossref","first-page":"e064604","DOI":"10.1136\/bmj-2021-064604","article-title":"The effects of plasma exchange in patients with ANCA-associated vasculitis: an updated systematic review and meta-analysis","volume":"376","author":"Walsh","year":"2022","journal-title":"BMJ"},{"key":"2023050208180076900_keac623-B106","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/art.40205","article-title":"Adding azathioprine to remission-induction glucocorticoids for eosinophilic granulomatosis with polyangiitis (Churg-Strauss), microscopic polyangiitis, or polyarteritis nodosa without poor prognosis factors: a randomized, controlled trial","volume":"69","author":"Pu\u00e9chal","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2023050208180076900_keac623-B107","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1136\/annrheumdis-2018-214245","article-title":"Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial","volume":"78","author":"Jones","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2023050208180076900_keac623-B108","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1136\/annrheumdis-2017-212861","article-title":"Trimethoprim-sulfamethoxazole prophylaxis prevents severe\/life-threatening infections following rituximab in antineutrophil cytoplasm antibody-associated vasculitis","volume":"77","author":"Kronbichler","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2023050208180076900_keac623-B109","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1056\/NEJMoa1404231","article-title":"Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis","volume":"371","author":"Guillevin","year":"2014","journal-title":"N Engl J Med"},{"key":"2023050208180076900_keac623-B110","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1136\/annrheumdis-2017-212878","article-title":"Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2)","volume":"77","author":"Charles","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2023050208180076900_keac623-B111","doi-asserted-by":"crossref","first-page":"179","DOI":"10.7326\/M19-3827","article-title":"Long-term rituximab use to maintain remission of antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial","volume":"173","author":"Charles","year":"2020","journal-title":"Ann Intern Med"},{"key":"2023050208180076900_keac623-B112","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1002\/art.34547","article-title":"Brief Report: long-term outcome of a randomized clinical trial comparing methotrexate to cyclophosphamide for remission induction in early systemic antineutrophil cytoplasmic antibody-associated vasculitis","volume":"64","author":"Faurschou","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2023050208180076900_keac623-B113","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1093\/ndt\/gfab357","article-title":"Induction and maintenance of remission with mycophenolate mofetil in ANCA-associated vasculitis: a systematic review and meta-analysis","volume":"37","author":"Berti","year":"2022","journal-title":"Nephrol Dial Transplant"},{"key":"2023050208180076900_keac623-B114","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1001\/jama.2010.1658","article-title":"Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trial","volume":"304","author":"Hiemstra","year":"2010","journal-title":"JAMA"},{"key":"2023050208180076900_keac623-B115","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2215\/CJN.06010809","article-title":"Mycophenolate mofetil for induction and maintenance of remission in microscopic polyangiitis with mild to moderate renal involvement\u2013a prospective, open-label pilot trial","volume":"5","author":"Silva","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"2023050208180076900_keac623-B116","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1136\/annrheumdis-2017-211123","article-title":"Randomised controlled trial of prolonged treatment in the remission phase of ANCA-associated vasculitis","volume":"76","author":"Karras","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2023050208180076900_keac623-B117","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1136\/annrheumdis-2011-200477","article-title":"Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up","volume":"71","author":"Harper","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2023050208180076900_keac623-B118","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","article-title":"KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases","volume":"100","year":"2021","journal-title":"Kidney Int"},{"key":"2023050208180076900_keac623-B119","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1681\/ASN.2019111197","article-title":"Efficacy of rituximab and plasma exchange in antineutrophil cytoplasmic antibody-associated vasculitis with severe kidney disease","volume":"31","author":"Casal Moura","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"2023050208180076900_keac623-B120","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s40620-015-0208-y","article-title":"Rituximab for treatment of severe renal disease in ANCA associated vasculitis","volume":"29","author":"Geetha","year":"2016","journal-title":"J Nephrol"},{"key":"2023050208180076900_keac623-B121","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/annrheumdis-2020-eular.2717","article-title":"Op0026 a randomized, controlled trial of rituximab versus azathioprine after induction of remission with rituximab for patients with anca-associated vasculitis and relapsing disease","volume":"79","author":"Smith","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2023050208180076900_keac623-B122","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1002\/art.34584","article-title":"Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener\u2019s): ten-year experience at a single center","volume":"64","author":"Cartin-Ceba","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2023050208180076900_keac623-B123","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12891-015-0860-3","article-title":"Low immunoglobulin levels increase the risk of severe hypogammaglobulinemia in granulomatosis with polyangiitis patients receiving rituximab","volume":"17","author":"Besada","year":"2016","journal-title":"BMC Musculoskelet Disord"},{"key":"2023050208180076900_keac623-B124","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/annrheumdis-2019-215882","article-title":"2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases","volume":"79","author":"Furer","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2023050208180076900_keac623-B125","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1136\/annrheumdis-2020-219773","article-title":"EULAR December 2020 view points on SARS-CoV-2 vaccination in patients with RMDs","volume":"80","author":"Bijlsma","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"2023050208180076900_keac623-B126","doi-asserted-by":"crossref","first-page":"e855","DOI":"10.1016\/S2665-9913(21)00316-7","article-title":"Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study","volume":"3","author":"Sattui","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"2023050208180076900_keac623-B127","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2007010090","article-title":"Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis","volume":"18","author":"Jayne","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"2023050208180076900_keac623-B128","article-title":". Presentation at EULAR 2022 congress, recommendation session","author":"Hellmich","year":"2022"},{"key":"2023050208180076900_keac623-B129","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.semarthrit.2020.02.008","article-title":"Disease and treatment-related morbidity in young and elderly patients with granulomatosis with polyangiitis and microscopic polyangiitis","volume":"50","author":"Berti","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"2023050208180076900_keac623-B130","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/rheumatology\/keu366","article-title":"Glucocorticoid treatment and damage in the anti-neutrophil cytoplasm antibody-associated vasculitides: long-term data from the European Vasculitis Study Group trials","volume":"54","author":"Robson","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"2023050208180076900_keac623-B131","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1681\/ASN.2013111233","article-title":"ANCA as a predictor of relapse: useful in patients with renal involvement but not in patients with nonrenal disease","volume":"26","author":"Kemna","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"2023050208180076900_keac623-B132","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/ndt\/gfaa066","article-title":"PR3-ANCAs predict relapses in ANCA-associated vasculitis patients after rituximab","volume":"36","author":"van Dam","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"2023050208180076900_keac623-B133","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1093\/rheumatology\/keaa541","article-title":"Long-term maintenance rituximab for ANCA-associated vasculitis: relapse and infection prediction models","volume":"60","author":"McClure","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2023050208180076900_keac623-B134","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1002\/art.39637","article-title":"Factors determining the clinical utility of serial measurements of antineutrophil cytoplasmic antibodies targeting proteinase 3","volume":"68","author":"Fussner","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2023050208180076900_keac623-B135","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/BOR.0000000000000233","article-title":"Usefulness of antineutrophil cytoplasmic autoantibodies in diagnosing and managing systemic vasculitis","volume":"28","author":"Kallenberg","year":"2016","journal-title":"Curr Opin Rheumatol"},{"key":"2023050208180076900_keac623-B136","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.2215\/CJN.01020113","article-title":"Renal survival in proteinase 3 and myeloperoxidase ANCA-associated systemic vasculitis","volume":"8","author":"de Joode","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"2023050208180076900_keac623-B137","first-page":"127","article-title":"ANCA and predicting relapse in systemic vasculitis","volume":"88","author":"Jayne","year":"1995","journal-title":"QJM"},{"key":"2023050208180076900_keac623-B138","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.autrev.2013.11.003","article-title":"Are anti-proteinase-3 ANCA a useful marker of granulomatosis with polyangiitis (Wegener\u2019s) relapses? Results of a retrospective study on 126 patients","volume":"13","author":"Thai","year":"2014","journal-title":"Autoimmun Rev"},{"key":"2023050208180076900_keac623-B139","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2215\/CJN.04160417","article-title":"The utility of urinalysis in determining the risk of renal relapse in ANCA-associated vasculitis","volume":"13","author":"Rhee","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"2023050208180076900_keac623-B140","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/annrheumdis-2013-203927","article-title":"Damage in the anca-associated vasculitides: long-term data from the European vasculitis study group (EUVAS) therapeutic trials","volume":"74","author":"Robson","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2023050208180076900_keac623-B141","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1136\/ard.2003.019125","article-title":"Urinary bladder cancer in Wegener\u2019s granulomatosis: risks and relation to cyclophosphamide","volume":"63","author":"Knight","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"2023050208180076900_keac623-B142","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1093\/rheumatology\/kep304","article-title":"Incidence and survival rates in Wegener\u2019s granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa","volume":"48","author":"Mohammad","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"2023050208180076900_keac623-B143","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.3899\/jrheum.160909","article-title":"Severe infection in antineutrophil cytoplasmic antibody-associated vasculitis","volume":"44","author":"Mohammad","year":"2017","journal-title":"J Rheumatol"},{"key":"2023050208180076900_keac623-B144","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1093\/rheumatology\/keaa699","article-title":"Incidence and predictors of severe infections in ANCA-associated vasculitis: a population-based cohort study","volume":"60","author":"Rathmann","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2023050208180076900_keac623-B145","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/rheumatology\/keab293","article-title":"Severe infections in patients with ANCA-associated vasculitis treated with rituximab","volume":"61","author":"Segelmark","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2023050208180076900_keac623-B146","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000509893","article-title":"Severe infections following rituximab treatment in antineutrophil cytoplasmic antibody-associated vasculitis","volume":"7","author":"Li","year":"2021","journal-title":"Kidney Dis"},{"key":"2023050208180076900_keac623-B147","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/s41584-022-00755-x","article-title":"COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations","volume":"18","author":"Grainger","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"2023050208180076900_keac623-B148","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/art.42030","article-title":"SARS-CoV-2 infection and COVID-19 outcomes in rheumatic disease: a systematic literature review and meta-analysis","volume":"74","author":"Conway","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"2023050208180076900_keac623-B149","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1136\/ard.2009.109389","article-title":"Early mortality in systemic vasculitis: relative contribution of adverse events and active vasculitis","volume":"69","author":"Little","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2023050208180076900_keac623-B150","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1517\/14740338.2016.1140743","article-title":"Long-term side effects of glucocorticoids","volume":"15","author":"Oray","year":"2016","journal-title":"Expert Opin Drug Saf"},{"key":"2023050208180076900_keac623-B151","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/qjmed\/90.6.391","article-title":"Damage occurs early in systemic vasculitis and is an index of outcome","volume":"90","author":"Exley","year":"1997","journal-title":"QJM"},{"key":"2023050208180076900_keac623-B152","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/rheumatology\/37.1.57","article-title":"Examination of disease severity in systemic vasculitis from the novel perspective of damage using the vasculitis damage index (VDI)","volume":"37","author":"Exley","year":"1998","journal-title":"Br J Rheumatol"},{"key":"2023050208180076900_keac623-B153","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3899\/jrheum.090387","article-title":"Predictors of damage and survival in patients with Wegener\u2019s granulomatosis: analysis of 50 patients","volume":"37","author":"Kamali","year":"2010","journal-title":"J Rheumatol"},{"key":"2023050208180076900_keac623-B154","doi-asserted-by":"crossref","first-page":"iii79","DOI":"10.1093\/rheumatology\/kez617","article-title":"Comorbidities in ANCA-associated vasculitis","volume":"59","author":"Kronbichler","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"2023050208180076900_keac623-B155","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/rheumatology\/kex338","article-title":"Cardiovascular events in anti-neutrophil cytoplasmic antibody-associated vasculitis: a meta-analysis of observational studies","volume":"57","author":"Houben","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"2023050208180076900_keac623-B156","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/art.40137","article-title":"2017 American College of Rheumatology guideline for the prevention and treatment of glucocorticoid-induced osteoporosis","volume":"69","author":"Buckley","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2023050208180076900_keac623-B157","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/joim.12586","article-title":"Excess mortality after hip fracture in elderly persons from Europe and the USA: the CHANCES project","volume":"281","author":"Katsoulis","year":"2017","journal-title":"J Intern Med"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keac623\/48291415\/keac623.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/5\/1787\/50120907\/keac623.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/62\/5\/1787\/50120907\/keac623.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T04:25:34Z","timestamp":1683001534000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/62\/5\/1787\/6782952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,31]]},"references-count":157,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,10,31]]},"published-print":{"date-parts":[[2023,5,2]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keac623","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,5,1]]},"published":{"date-parts":[[2022,10,31]]}}}